{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:15:21Z","timestamp":1788322521252,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.parkreldis.2019.10.022","type":"journal-article","created":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T20:48:41Z","timestamp":1571777321000},"page":"40-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Effects of augmenting cholinergic neurotransmission on balance in Parkinson's disease"],"prefix":"10.1016","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4532-3984","authenticated-orcid":false,"given":"Martina","family":"Mancini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Zajack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5131-497X","authenticated-orcid":false,"given":"Douglas N.","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Ramsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodi","family":"Lapidus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fay B.","family":"Horak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Nutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.parkreldis.2019.10.022_bib1","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/mds.27195","article-title":"Falls in Parkinson's disease: a complex and evolving picture","volume":"32","author":"Fasano","year":"2017","journal-title":"Mov. Disord."},{"issue":"8","key":"10.1016\/j.parkreldis.2019.10.022_bib2","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1177\/1545968314565511","article-title":"A randomized controlled trial to reduce falls in people with Parkinson's disease","volume":"29","author":"Morris","year":"2015","journal-title":"Neurorehabilitation Neural Repair"},{"issue":"20","key":"10.1016\/j.parkreldis.2019.10.022_bib3","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1212\/WNL.0b013e3181c1ded6","article-title":"History of falls in Parkinson disease is associated with reduced cholinergic activity","volume":"73","author":"Bohnen","year":"2009","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.parkreldis.2019.10.022_bib4","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/mds.26269","article-title":"Levodopa is a double-edged sword for balance and gait in people with Parkinson's disease","volume":"30","author":"Curtze","year":"2015","journal-title":"Mov. Disord."},{"issue":"9","key":"10.1016\/j.parkreldis.2019.10.022_bib5","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s11910-013-0377-9","article-title":"Cholinergic dysfunction in Parkinson's disease","volume":"13","author":"Muller","year":"2013","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"29","key":"10.1016\/j.parkreldis.2019.10.022_bib6","doi-asserted-by":"crossref","first-page":"11986","DOI":"10.1523\/JNEUROSCI.1568-13.2013","article-title":"Gait disorders in parkinsonian monkeys with pedunculopontine nucleus lesions: a tale of two systems","volume":"33","author":"Grabli","year":"2013","journal-title":"J. Neurosci."},{"issue":"18","key":"10.1016\/j.parkreldis.2019.10.022_bib7","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1212\/WNL.0b013e3182a9f558","article-title":"Gait speed in Parkinson disease correlates with cholinergic degeneration","volume":"81","author":"Bohnen","year":"2013","journal-title":"Neurology"},{"issue":"Pt 11","key":"10.1016\/j.parkreldis.2019.10.022_bib8","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1093\/brain\/awt247","article-title":"Thalamic cholinergic innervation and postural sensory integration function in Parkinson's disease","volume":"136","author":"Muller","year":"2013","journal-title":"Brain"},{"issue":"Pt 9","key":"10.1016\/j.parkreldis.2019.10.022_bib9","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1093\/brain\/aws207","article-title":"Cholinergic dysfunction contributes to gait disturbance in early Parkinson's disease","volume":"135","author":"Rochester","year":"2012","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.parkreldis.2019.10.022_bib10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s40268-014-0038-8","article-title":"Effect of rivastigmine on mobility of patients with higher-level gait disorder: a pilot exploratory study","volume":"14","author":"Gurevich","year":"2014","journal-title":"Drugs R"},{"issue":"14","key":"10.1016\/j.parkreldis.2019.10.022_bib11","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1212\/WNL.0b013e3181f6128c","article-title":"Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease","volume":"75","author":"Chung","year":"2010","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.parkreldis.2019.10.022_bib12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1474-4422(15)00389-0","article-title":"Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"15","author":"Henderson","year":"2016","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.parkreldis.2019.10.022_bib13","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1123\/mc.2017-0033","article-title":"Can postural control asymmetry predict falls in people with Parkinson's disease?","volume":"22","author":"Beretta","year":"2018","journal-title":"Mot. Control"},{"issue":"4","key":"10.1016\/j.parkreldis.2019.10.022_bib14","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/01376517-200008000-00006","article-title":"Fall risk factors in Parkinson's disease","volume":"32","author":"Gray","year":"2000","journal-title":"J. Neurosci. Nurs."},{"issue":"11","key":"10.1016\/j.parkreldis.2019.10.022_bib15","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1007\/s00415-017-8620-y","article-title":"Natural history of falls in an incident cohort of Parkinson's disease: early evolution, risk and protective features","volume":"264","author":"Lord","year":"2017","journal-title":"J. Neurol."},{"issue":"5","key":"10.1016\/j.parkreldis.2019.10.022_bib16","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/mds.10396","article-title":"Fear of falling and postural control in Parkinson's disease","volume":"18","author":"Adkin","year":"2003","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.parkreldis.2019.10.022_bib17","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1212\/WNL.0b013e3181e7b688","article-title":"Predictors of future falls in Parkinson disease","volume":"75","author":"Kerr","year":"2010","journal-title":"Neurology"},{"issue":"3\u20134","key":"10.1016\/j.parkreldis.2019.10.022_bib18","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00221-011-2551-0","article-title":"Postural instability and fall risk in Parkinson's disease: impaired dual tasking, pacing, and bilateral coordination of gait during the \u201cON\u201d medication state","volume":"210","author":"Plotnik","year":"2011","journal-title":"Exp. Brain Res."},{"issue":"1","key":"10.1016\/j.parkreldis.2019.10.022_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000089820","article-title":"Force platform measurements as predictors of falls among older people - a review","volume":"52","author":"Piirtola","year":"2006","journal-title":"Gerontology"},{"key":"10.1016\/j.parkreldis.2019.10.022_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/572134","article-title":"Exploring outcome measures for exercise intervention in people with Parkinson's disease","author":"King","year":"2013","journal-title":"Parkinson's Dis."},{"issue":"4","key":"10.1016\/j.parkreldis.2019.10.022_bib21","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.humov.2007.05.003","article-title":"Gait dynamics, fractals and falls: finding meaning in the stride-to-stride fluctuations of human walking","volume":"26","author":"Hausdorff","year":"2007","journal-title":"Hum. Mov. Sci."},{"issue":"19","key":"10.1016\/j.parkreldis.2019.10.022_bib22","article-title":"Gait variability: methods, modeling and meaning","volume":"2","author":"Hausdorff","year":"2005","journal-title":"J. NeuroEng. Rehabil."},{"issue":"1\u20132","key":"10.1016\/j.parkreldis.2019.10.022_bib23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-510X(03)00104-7","article-title":"Gait dynamics in Parkinson's disease: relationship to Parkinsonian features, falls and response to levodopa","volume":"212","author":"Schaafsma","year":"2003","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2019.10.022_bib24","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s12883-015-0523-x","article-title":"Effect of augmenting cholinergic function on gait and balance","volume":"15","author":"Mancini","year":"2015","journal-title":"BMC Neurol."},{"key":"10.1016\/j.parkreldis.2019.10.022_bib25","first-page":"002","article-title":"Are cholinesterase inhibitors effective in improving balance in Parkinson's disease?","volume":"S2","author":"Hiller","year":"2015","journal-title":"J. Neurol. Disord."},{"issue":"2","key":"10.1016\/j.parkreldis.2019.10.022_bib26","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1469-7793.2000.t01-1-00503.x","article-title":"Short latency inhibition of human hand motor cortex by somatosensory input from the hand","volume":"523","author":"Tokimura","year":"2000","journal-title":"J. Physiol."},{"issue":"1\u20132","key":"10.1016\/j.parkreldis.2019.10.022_bib27","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000438824","article-title":"Impact of rivastigmine on cognitive dysfunction and falling in Parkinson's disease patients","volume":"74","author":"Li","year":"2015","journal-title":"Eur. Neurol."},{"issue":"2","key":"10.1016\/j.parkreldis.2019.10.022_bib28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/mds.26061","article-title":"Clinical markers for identifying cholinergic deficits in Parkinson's disease","volume":"30","author":"Muller","year":"2015","journal-title":"Mov. Disord."},{"issue":"Pt 8","key":"10.1016\/j.parkreldis.2019.10.022_bib29","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1093\/brain\/awg183","article-title":"Short and long latency afferent inhibition in Parkinson's disease","volume":"126","author":"Sailer","year":"2003","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.parkreldis.2019.10.022_bib30","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/jnnp.2004.038729","article-title":"Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzheimer's disease","volume":"76","author":"Bohnen","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"6","key":"10.1016\/j.parkreldis.2019.10.022_bib31","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/00004714-200212000-00012","article-title":"Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease","volume":"22","author":"Kaasinen","year":"2002","journal-title":"J. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.parkreldis.2019.10.022_bib32","first-page":"211","article-title":"Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis","volume":"3","author":"Hansen","year":"2008","journal-title":"Clin. Interv. Aging"},{"issue":"6","key":"10.1016\/j.parkreldis.2019.10.022_bib33","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/ana.23874","article-title":"Cholinergic enhancement of functional networks in older adults with mild cognitive impairment","volume":"73","author":"Pa","year":"2013","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.parkreldis.2019.10.022_bib34","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nrd4295","article-title":"Muscarinic acetylcholine receptors: novel opportunities for drug development","volume":"13","author":"Kruse","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.parkreldis.2019.10.022_bib35","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3389\/fneur.2019.00424","article-title":"Nicotine bitartrate reduces falls and freezing of gait in Parkinson disease: a reanalysis","volume":"10","author":"Lieberman","year":"2019","journal-title":"Front. Neurol."},{"issue":"3","key":"10.1016\/j.parkreldis.2019.10.022_bib36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1519\/JPT.0b013e3182abe784","article-title":"Impact of Tai Chi Chu'an practice on balance and mobility in older adults: an integrative review of 20 years of research","volume":"37","author":"Hackney","year":"2014","journal-title":"J. Geriatr. Phys. Ther."},{"issue":"3","key":"10.1016\/j.parkreldis.2019.10.022_bib37","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1109\/JBHI.2015.2419317","article-title":"Validation of an accelerometer to quantify a comprehensive battery of gait characteristics in healthy older adults and Parkinson's disease: toward clinical and at home use","volume":"20","author":"Del Din","year":"2016","journal-title":"IEEE J Biomed Health Inform"},{"issue":"10","key":"10.1016\/j.parkreldis.2019.10.022_bib38","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/mds.25098","article-title":"Donepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study","volume":"27","author":"Dubois","year":"2012","journal-title":"Mov. Disord."},{"issue":"24","key":"10.1016\/j.parkreldis.2019.10.022_bib39","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa041470","article-title":"Rivastigmine for dementia associated with Parkinson's disease","volume":"351","author":"Emre","year":"2004","journal-title":"N. Engl. J. Med."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802019304493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802019304493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:16:58Z","timestamp":1761178618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802019304493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":39,"alternative-id":["S1353802019304493"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2019.10.022","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of augmenting cholinergic neurotransmission on balance in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2019.10.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}